{"id":"W4387016096","doi":"10.1016/j.jaad.2023.07.773","title":"42307 Matching-adjusted indirect comparison of efficacy of ixekizumab versus secukinumab through 1 year in pediatric patients with severe plaque psoriasis","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Health Sciences Centre; Probity Medical Research; Calgary Laboratory Services; Sunnybrook Health Science Centre; SKiN Health; University of Calgary","funders":"","keywords":"Ixekizumab; Secukinumab; Medicine; Etanercept; Psoriasis; Dermatology; Plaque psoriasis; Placebo; Clinical trial; Internal medicine; Tumor necrosis factor alpha; Psoriatic arthritis; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003108875,0.0008008342,0.001863475,0.0003882826,0.000266488,0.0007572251,0.0009292769,0.00114045,0.003880915],"category_scores_gemma":[0.006111223,0.00073431,0.005760774,0.0007729348,0.0003396735,0.0008042027,0.0007029384,0.001671978,0.0002867988],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009258187,"about_ca_system_score_gemma":0.0009559819,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0107921,"about_ca_topic_score_gemma":0.008151602,"domain_scores_codex":[0.996292,0.002145726,0.0002762348,0.0006473613,0.0002420898,0.0003966527],"domain_scores_gemma":[0.9969946,0.001506953,0.0007621525,0.0003850127,0.0001579769,0.0001932597],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.5352848,0.001819599,0.3539608,0.001295693,0.06367809,0.000327765,0.0002468493,0.005415131,0.001902578,0.0005674224,0.00227303,0.03322828],"study_design_scores_gemma":[0.05896304,0.07242728,0.7934285,0.0002722539,0.05902384,0.000456083,0.0004166386,0.009640844,0.001637181,0.0006499529,0.002984664,0.00009975025],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9964192,0.001502747,0.0002822467,0.00007095961,0.00008615469,0.00004343114,0.0009945194,0.00001364206,0.0005871098],"genre_scores_gemma":[0.9982346,0.0003038869,0.0002198762,0.00005899578,0.00003091254,0.00004755391,0.0006629684,0.000005425192,0.0004356925],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0107921,"threshold_uncertainty_score":0.02145857,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02501251088921918,"score_gpt":0.2881654607279379,"score_spread":0.2631529498387187,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}